An investigation for investors in NASDAQ:OFIX shares was announced concerning possibl breaches of fiduciary duties by certain Orthofix International directors.
Investors who purchased shares of Orthofix International NV (NASDAQ:OFIX) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Orthofix International directors breached their fiduciary duties and caused damage to the company and its shareholders.
On December 16, 2016, an article was published alleging that the “FDA is actively moving to ‘down classify’ BGS from Class III to Class II, allowing cheap competition to flood in, stealing revenues and crushing margins.” The article further revealed that “as of October 1st, 2016 (about 10 weeks ago) the FDA just transferred the BGS down classification process to the specific department responsible for handling the down classification (the department of Orthopedics).”
Shares of Orthofix International NV (NASDAQ:OFIX) declined on December 16, 2016, to as low as $32.75 per share.
On January 10, 2017 NASDAQ:OFIX shares closed at $36.88 per share.
Those who purchased NASDAQ:OFIX shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego